SCHEMBL5375181

SCHEMBL5375181

Cc1ccc(S(=O)(=O)N(c2ccccc2)c2ccc3ncsc3c2)cc1C(=O)O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.46
MAPK1 P28482 1/20 0.46
KDM4E B2RXH2 4/20 0.41
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
HKDC1 Q2TB90 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
ALDH1A1 P00352 5/20 0.39
LMNA P02545 4/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
MEN1 O00255 4/20 0.38
KMT2A Q03164 4/20 0.38
NPSR1 Q6W5P4 1/20 0.38
PDE4B Q07343 1/20 0.37
ESR1 P03372 1/20 0.37
PDE10A Q9Y233 1/20 0.36
HPGD P15428 2/20 0.36
PKM P14618 1/20 0.36
ALOX15 P16050 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5921904 0.90 MAPT (0.46) MAPTMAPK1KDM4ENPC1RAB9A
SCHEMBL5377050 0.80 SMN1; SMN2 (0.41) MAPTKDM4ENPC1RAB9AL3MBTL1
SCHEMBL4789752 0.73 MAPT (0.65) MAPTMAPK1KDM4ENPC1RAB9A
SCHEMBL5374543 0.71 POLB (0.43) MAPTTDP1ALDH1A1LMNASMN1; SMN2
SCHEMBL5921913 0.71 SMN1; SMN2 (0.40) MAPTKDM4ENPC1RAB9AALDH1A1
SCHEMBL5395468 0.69 LMNA (0.45) MAPTTDP1ALDH1A1LMNAMEN1
SCHEMBL5716848 0.69 CASP3 (0.42) MAPTKDM4ENPC1RAB9AALDH1A1
Toluic Acid SCHEMBL18498518 0.67 ALDH1A1 (0.58) MAPTKDM4ENPC1RAB9AL3MBTL1
SCHEMBL11819253 0.67 KMT2A (0.67) KDM4EL3MBTL1ALDH1A1LMNASMN1; SMN2
SCHEMBL11821929 0.67 ESR1 (0.53) MAPTKDM4EALDH1A1LMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-20060258723-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PFIZER INC 2006-11-16 US disclosed
US-20050228015-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-10-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050228015-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD MAPT 1786/4885MAPK1 3366/4885KDM4E 3834/4885
US-20060258723-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARG, PPARA, PPARD MAPT 1984/4885MAPK1 3481/4885KDM4E 3815/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.